Recently Viewed

News Announcement

Strides Pharma Science: Announcement under Regulation 30 (LODR)-Press Release / Media Release

22-Dec-2022 Follow Value Research Online on Google download pdfDownload PDF Strides Pharma

Receipt of AUD 94 million on account of deferred consideration on the sale of the Companys Australian operations in 2019

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.